Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Diabetes and Endo
    • Metformin and insulin...

    Metformin and insulin ineffective in children with type 2 diabetes

    Written by Medha Baranwal Baranwal Published On 2018-07-16T19:25:58+05:30  |  Updated On 16 July 2018 7:25 PM IST
    Metformin and insulin ineffective in children with type 2 diabetes

    Treatment with neither 3 months of insulin followed by 9 months of metformin nor 12 months of metformin alone was effective in treating children with recently diagnosed type 2 diabetes, finds a new study. The study published in the journal Diabetes Care finds that the medications did not halt the decline of insulin production.


    Sonia Caprio, Department of Pediatric Endocrinology, Yale School of Medicine, New Haven, Connecticut, and colleagues conducted The RISE Pediatric Medication Study to compare two approaches—glargine followed by metformin with metformin alone—in preserving or improving β-cell function in youth with impaired glucose tolerance (IGT) or recently diagnosed T2D during and after therapy withdrawal.


    The prevalence of pediatric type 2 diabetes is increasing worldwide, and researchers are striving for ways to lessen insulin resistance and prevent beta cell dysfunction.


    In adults, insulin resistance can be reversed through eating a healthy, real food diet, and as evidenced by our Low Carb Program users are able to come off diabetes medication and put the condition into remission.


    While some studies have shown low carb diets for children with diabetes can lead to weight loss and improved blood sugar control, there is a lack of clinical studies into low carb eating and children.


    Read Also: Children who sleep an hour less at higher risk of type 2 diabetes, says study

    Metformin is a first-line treatment in type 2 diabetes, helping to lower blood sugar levels, while Lantus (glargine) insulin may be used among those who've struggled to control their blood sugar through diet, lifestyle changes, and other medication.


    In this new trial, the researchers recruited 91 overweight or obese children aged 10-19 who either had T2D or IGT. They were then randomized to injections of Lantus (glargine) insulin for three months followed by metformin for three months or metformin for a year.


    During the 15-month study period, blood sugar levels and beta-cell function were monitored by researchers. Neither treatment slowed or stopped type 2 diabetes progression in either group, and beta cell deterioration continued despite the treatments.


    The researchers hypothesized the lack of effectiveness may be due to the more aggressive nature of type 2 diabetes in youth. She added that newer medications that target insulin resistance in youth may be required.


    "In youth with IGT or recently diagnosed type 2 diabetes, neither 3 months of glargine followed by 9 months of metformin nor 12 months of metformin alone halted the progressive deterioration of β-cell function. Alternate approaches to preserve β-cell function in youth are needed," concluded the authors.


    For more information follow the link: https://doi.org/10.2337/dc18-0787
    beta cellblood sugarchildrendiabetesDiabetes Careglargineglucose intoleranceinsulinLantusmedicationmetforminpediatricstreatmentType-2 diabetesyouth
    Source : With inputs from Diabetes Care

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok